Summary of the Conference Call for Juzi Biotechnology Company Overview - Company: Juzi Biotechnology - Industry: Biotechnology and Cosmetics Key Points and Arguments 1. Transparency and Consumer Trust - Juzi Biotechnology plans to enhance transparency by inviting consumers to visit factories and film production processes to rebuild trust following recent public sentiment issues [2][4][8] - The company will conduct interactive activities such as bottle recycling and collaborate with clinical research institutions to strengthen its medical background and credibility [2][6] 2. Product Quality and Standards - The company is addressing challenges in detecting recombinant collagen in cosmetics by collaborating with research institutions to optimize detection methods and participate in the establishment of industry standards [5][6] - Juzi Biotechnology emphasizes that all products are produced according to registered formulas and processes, ensuring compliance with cosmetic technical requirements [3] 3. Sales Strategy Post-Pandemic - Following the pandemic, the company plans to adjust its sales strategies, including resuming collaborations with influencers to regain market share [7][10] - The sales strategy will focus on three dimensions: acquiring new customers, maintaining existing customers, and enhancing product presentation [10] 4. Performance and Growth Expectations - The company reported that offline sales channels performed well in the first half of the year, with growth across hospitals, pharmacies, and CSK channels, slightly exceeding initial targets [11] - During the 618 shopping festival, Juzi Biotechnology ranked second in Tmall's domestic beauty sales, with core products performing well despite a temporary increase in return rates [12] 5. Financial Impact of Public Sentiment - The profit margin remained unaffected in the first half of the year, as the decline in online sales was offset by higher offline margins [13] - The company anticipates that increased marketing and promotional activities will be necessary to restore consumer confidence, but these costs will be manageable and not significantly alter the overall expense ratio [13] 6. Product Development and Market Position - Juzi Biotechnology's other core products, primarily Class II medical devices, have not been significantly impacted by public sentiment and continue to grow rapidly in offline sales [14] - The company is actively promoting new products, including the upgraded "Big Devil" cream, and plans to continue its marketing efforts in 2025 [15] Additional Important Information - The company is committed to scientific communication to enhance consumer understanding of its 20+ years of R&D capabilities and technical expertise [6][8] - Juzi Biotechnology aims to establish a strong presence in both public and private hospital channels, leveraging professional endorsements to build brand trust [8]
巨子生物20250624